Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-04-22 Purchase | 2024-04-24 6:31 pm | GlucoTrack Inc. | GCTK | SYCOFF DREW Director 10% Owner | 182,540 | $1.26 | $230,000 | 2,951,258 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-11-14 Option Award | 2025-03-31 09:20 am | 2025-01-03 2030-01-03 | Glucotrack Inc. | GCTK | John A. Ballantyne Revocable Living Trust dated 08/01/2017 10% Owner | 264,072 | $0 | 3,381,817 (Direct) | View |
2025-03-12 Exercise | 2025-03-31 09:20 am | 2025-01-03 2027-07-03 | Glucotrack Inc. | GCTK | John A. Ballantyne Revocable Living Trust dated 08/01/2017 10% Owner | 2,692,589 | $0 | 3,381,817 (Direct) | View |
2024-11-14 Other | 2025-03-31 09:20 am | N/A N/A | Glucotrack Inc. | GCTK | John A. Ballantyne Revocable Living Trust dated 08/01/2017 10% Owner | 132,036 | $31 | 3,381,817 (Direct) | View |
2024-11-14 Option Award | 2025-03-31 08:54 am | 2025-01-03 2030-01-03 | Glucotrack Inc. | GCTK | BALLANTYNE JOHN Director 10% Owner | 268,198 | $0 | 3,385,943 (Indirect) | View |
2025-03-12 Exercise | 2025-03-31 08:54 am | 2025-01-03 2027-07-03 | Glucotrack Inc. | GCTK | BALLANTYNE JOHN Director 10% Owner | 2,692,589 | $0 | 3,385,943 (Indirect) | View |
2024-11-14 Other | 2025-03-31 08:54 am | N/A N/A | Glucotrack Inc. | GCTK | BALLANTYNE JOHN Director 10% Owner | 132,036 | $31 | 3,385,943 (Indirect) | View |
2024-11-14 Option Award | 2025-03-31 08:17 am | 2030-01-03 2027-07-03 | Glucotrack Inc. | GCTK | Malave Luis Director | 16,971 | $0 | 357,389 (Direct) | View |
2025-03-12 Exercise | 2025-03-31 08:17 am | 2030-01-03 2027-07-03 | Glucotrack Inc. | GCTK | Malave Luis Director | 140,418 | $0 | 357,389 (Direct) | View |
2024-11-14 Conversion | 2025-03-31 08:17 am | N/A N/A | Glucotrack Inc. | GCTK | Malave Luis Director | 6,886 | $31.2 | 357,389 (Direct) | View |
2024-11-14 Conversion | 2025-03-31 08:17 am | N/A N/A | Glucotrack Inc. | GCTK | Malave Luis Director | 214,831 | $214,831 | 357,389 (Direct) | View |
2024-11-14 Conversion | 2025-03-31 07:52 am | N/A N/A | Glucotrack Inc. | GCTK | Carter Erin Catherine Director | 64,831 | $64,831 | 99,788 (Direct) | View |
2024-11-14 Option Award | 2025-03-31 07:52 am | 2025-01-03 2030-01-03 | Glucotrack Inc. | GCTK | Carter Erin Catherine Director | 7,413 | $0 | 99,788 (Direct) | View |
2025-03-12 Exercise | 2025-03-31 07:52 am | 2030-01-03 2027-07-03 | Glucotrack Inc. | GCTK | Carter Erin Catherine Director | 42,375 | $0 | 99,788 (Direct) | View |
2024-11-14 Conversion | 2025-03-31 07:52 am | N/A N/A | Glucotrack Inc. | GCTK | Carter Erin Catherine Director | 2,078 | $31.2 | 99,788 (Direct) | View |
2024-06-14 Option Award | 2025-03-28 9:43 pm | N/A 2034-06-14 | Glucotrack Inc. | GCTK | Goode Paul Chief Executive Officer | 4,869 | $0 | 37,458 (Direct) | View |
2025-03-12 Exercise | 2025-03-28 9:43 pm | 2025-01-03 2027-07-03 | Glucotrack Inc. | GCTK | Goode Paul Chief Executive Officer | 16,231 | $0 | 37,458 (Direct) | View |
2024-11-14 Conversion | 2025-03-28 9:43 pm | N/A N/A | Glucotrack Inc. | GCTK | Goode Paul Chief Executive Officer | 796 | $31.2 | 37,458 (Direct) | View |
2025-02-05 Other | 2025-03-28 9:43 pm | N/A N/A | Glucotrack Inc. | GCTK | Goode Paul Chief Executive Officer | 1,500 | $0 | 37,458 (Direct) | View |
2024-11-14 Conversion | 2025-03-28 9:43 pm | N/A N/A | Glucotrack Inc. | GCTK | Goode Paul Chief Executive Officer | 24,831 | $24,831 | 37,458 (Direct) | View |
2022-10-04 Option Award | 2025-03-28 9:05 pm | N/A N/A | Glucotrack Inc. | GCTK | Danzig Allen Director | 1,771 | $0 | 1,922 (Direct) | View |
2025-03-26 Option Award | 2025-03-28 8:57 pm | N/A N/A | Glucotrack Inc. | GCTK | Balo Andrew K Director | 4,490 | $0 | 4,490 (Direct) | View |
2021-08-24 Option Award | 2025-03-28 8:53 pm | N/A N/A | Glucotrack Inc. | GCTK | Fischell Robert Director | 2,045 | $0 | 2,045 (Direct) | View |
Ownership | 2025-03-28 8:31 pm | N/A N/A | Glucotrack Inc. | GCTK | John A. Ballantyne Revocable Living Trust dated 08/01/2017 10% Owner | 0 | $0 | 51,002 (Direct) | View |
Ownership | 2024-11-22 4:09 pm | N/A N/A | Glucotrack Inc. | GCTK | BALLANTYNE JOHN Director 10% Owner | 0 | $0 | 1,020,033 (Indirect) | View |
Ownership | 2024-04-24 9:00 pm | N/A N/A | GlucoTrack Inc. | GCTK | Goode Paul Chief Executive Officer | 0 | $0 | 398,820 (Direct) | View |
Ownership | 2022-08-10 1:12 pm | N/A N/A | GlucoTrack Inc. | GCTK | Danzig Allen Director | 0 | $0 | 15,048 (Direct) | View |